| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cervical Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Squamous Cell | |||||
| Uterine Cervical Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| Genital Diseases, Female | |||||
| Genital Neoplasms, Female | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Squamous Cell | |||||
| Urogenital Neoplasms | |||||
| Uterine Cervical Diseases | |||||
| Uterine Diseases | |||||
| Uterine Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| cisplatin | |||||
| topotecan hydrochloride | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Topotecan | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Gynecologic Oncology Group | |||||
| National Cancer Institute (NCI) | |||||
| Eastern Cooperative Oncology Group | |||||
|
